Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1096 AL 1110

Relationships between Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases: Clinical Assessments, Biomarkers, and Treatment

Li M, Wang L, Liu JH, Zhan SQ.

Chin Med J (Engl). 2018 Apr 20;131(8):966-973. doi: 10.4103/0366-6999.229886.

Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management

Shen Y, Huang JY, Li J, Liu CF.

Chin Med J (Engl). 2018 Apr 20;131(8):974-981. doi: 10.4103/0366-6999.229889.

Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study

Mestre TA, Pont-Sunyer C, Kausar F, Visanji NP, Ghate T, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kasten M, Wadia PM, Zadikoff C, Kumar P, de Bie RM, Thomsen T, Lang AE, Schüle B, Klein C, Tolosa E, Marras C.

Mov Disord. 2018 Jul;33(6):960-965. doi: 10.1002/mds.27272. Epub 2018 Apr 17.

Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics

Pan Y, Nicolazzo JA.

Adv Drug Deliv Rev. 2018 Oct;135:62-74. doi: 10.1016/j.addr.2018.04.009. Epub 2018 Apr 14.

Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications

Lappin JM, Darke S, Farrell M.

Drug Alcohol Depend. 2018 Jun 1;187:134-140. doi: 10.1016/j.drugalcdep.2018.02.032. Epub 2018 Apr 10.

Nintendo Wii™ Versus Xbox Kinect™ for Assisting People With Parkinson's Disease

Alves MLM, Mesquita BS, Morais WS, Leal JC, Satler CE, Dos Santos Mendes FA.

Percept Mot Skills. 2018 Jun;125(3):546-565. doi: 10.1177/0031512518769204. Epub 2018 Apr 17.

Insights into Parkinson's disease from computational models of the basal ganglia

Humphries MD, Obeso JA, Dreyer JK.

J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1181-1188. doi: 10.1136/jnnp-2017-315922. Epub 2018 Apr 17.

Levodopa-Responsive Early-Onset Parkinsonism in Down Syndrome

Palat P, Hickey F, Patel L, Sannar E.

Case Rep Neurol Med. 2018 Feb 15;2018:2314791. doi: 10.1155/2018/2314791. eCollection 2018.

Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells

LaMarca EA, Powell SK, Akbarian S, Brennand KJ.

Front Pediatr. 2018 Apr 3;6:82. doi: 10.3389/fped.2018.00082. eCollection 2018.

Association between physical fitness, cardiovascular risk factors, and Parkinson's disease

Müller J, Myers J.

Eur J Prev Cardiol. 2018 Sep;25(13):1409-1415. doi: 10.1177/2047487318771168. Epub 2018 Apr 18.

Prognostic factors of functional outcome after hip fracture surgery: a systematic review

Sheehan KJ, Williamson L, Alexander J, Filliter C, Sobolev B, Guy P, Bearne LM, Sackley C.

Age Ageing. 2018 Sep 1;47(5):661-670. doi: 10.1093/ageing/afy057.

Neuropsychological Test Performance in Parkinsonism Without Dopaminergic Deficiency on [123I]-FP-CIT SPECT Imaging

Wyman-Chick KA, Martin PK, Minár M, Menéndez-González M, Erickson LO, Álvarez-Avellón T, Schroeder RW.

J Int Neuropsychol Soc. 2018 Jul;24(6):646-651. doi: 10.1017/S1355617718000164. Epub 2018 Apr 19.

Von Economo's disease and postencephalitic parkinsonism responsive to carbidopa and levodopa

Bigman DY, Bobrin BD.

Neuropsychiatr Dis Treat. 2018 Apr 4;14:927-931. doi: 10.2147/NDT.S153313. eCollection 2018.

Safinamide: an add-on treatment for managing Parkinson's disease

Müller T.

Clin Pharmacol. 2018 Apr 5;10:31-41. doi: 10.2147/CPAA.S137740. eCollection 2018.

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer's Disease, and Parkinson's Disease

Hsu WY, Lane HY, Lin CH.

Front Psychiatry. 2018 Apr 4;9:91. doi: 10.3389/fpsyt.2018.00091. eCollection 2018.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias